Paul Sargos: Short update on local and metastases directed treatments for MHSPC
Paul Sargos, Head of the Radiology Department at Bergonie Institute, shared a post X about his recent paper published in European Oncology Focus:
“Before PEACE 1 to be published soon, read our short update on local and metastases directed treatments for MHSPC (Metastatic hormone-sensitive prostate cancer).
Just out in European Oncology Focus.”
“Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate Cancer”
Authors: Nicolas Benziane-Ouaritini, Alberto Bossi, Paul Sargos.
More posts featuring Paul Sargos.
Paul Sargos is the Head of the Radiology Department at the Bergonie Institute and works as a radiotherapist at Charlebourg-La Defense in Paris. He specializes in genitourinary cancers and soft tissue sarcomas, with an emphasis on clinical research.
Dr. Sargos is an active member of several professional organizations, including GETUG, AFU, GFRU, and GSF-GETO. He also plays a role as a co-organizer for the FOCUS, GFRU, and UDOU conferences in Saint-Paul de Vence.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023